Abstract

Background: Haematological manifestations are the second commonest cause of morbidity and one of thecommon causes of mortality in HIV patients. In the course of ART administration, clinically significant haematologic abnormalities are common in persons with HIV infection. Objectives: To study the comparison of haematological parameters in subjects with different CD4 counts, to compare haematological findings of pre-ART group with ART group and two ART regimens namely ZLN and TLE. Study Design: Prospective observational study. Material and Methods: After obtaining informed consent, 225 PLHIV were clinically evaluated and subjected to CBC, PBS, ALC, ESR and CD4 count. Statistical Analysis: Data was expressed as percentage and mean ± standard deviation. Statistical tests used were chi-square test, Fisher’s exact test and Mann-Whitney U test and Kolmogorov-smirnov analysis. Results: TLC (p=0.02), MCV(p=0.04) and ALC (p<0.0003) were significantly raised while Hb, MCH, MCHC, PCV, ESR, CD4 count showed Non significant raised values in ART group in comparison to pre-ART group. MCH (p=0.01) and ALC (p<0.001) were significantly raised and Hb, MCHC, PCV, ESR, ALC showed Non significant raised values in PLHIV on TLE regimen when compared to ZLN regimen while TLC (p=0.04) was significantly raised in ZLN regimen. Conclusion: Most significant parameter was ALC in comparison between treated and untreated PLHIV groups and two ART regimens. TLE regimen fared better than ZLN regimen in treatment of PLHIV.

• 1.   Ghosh TK. AIDS: a serious challenge to public health. J Indian Med Assoc. 1986;84(1):29-30.
• 2.   Panda S, Chatterjee A, Abdul-Quader AS. Living with the AIDS virus: the epidemic and the response in India. New Delhi: Sage Publications; 2002. p. 20.
• 3.   Sande MA, Volberding PA, editors. The medical management of AIDS. 4th ed. Philadelphia: W.B. Saunders; 1995.
• 4.   Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood. 1998;91(5):1479-95.
• 5.   National AIDS Control Organisation (NACO). Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposure prophylaxis. New Delhi: Ministry of Health and Family Welfare, Government of India; 2007 May. p. 7-19.
• 6.   Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of haematological abnormalities of Indian HIV infected individuals. BMC Blood Disord. 2009;9:5.
• 7.   Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of haematological abnormalities of Indian HIV infected individuals. BMC Blood Disord. 2009;9:5.
• 8.   Sieg SF, Harding CV, Lederman MM. HIV-1 infection impairs cell cycle progression of CD4+ T cells without affecting early activation responses. J Clin Invest. 2001;108(5):757-64.
• 9.   Enawgaw B, Alem B, Addis Z, Melku M. Determination of haematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative cross-sectional study. BMC Hematol. 2014;14:8.
• 10.   Ibeh BO, Omodamiro OD, Ibeh U, Habu JB. Biochemical and haematological changes in HIV subjects receiving winniecure antiretroviral drug in Nigeria. J Biomed Sci. 2013;20(1):73.
• 11.   Amegor OF, Bigila DA, Oyesola OA, Oyesola TO, Buseni ST. Hematological changes in HIV patients placed on anti retroviral therapy in Markurdi, Benue State of Nigeria. Asian J Epidemiol. 2009;2(4):97-103. (Note: I added the missing article title
• 12.   • Lowe DM. The ESR in HIV: a neglected parameter? AIDS. 2010;24(18):2773-5.
• 13.   • Kovacs JA, Vogel S, Albert JM, Falloon J, Davey RT Jr, Walker RE, et al. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med. 1996;335(18):1350-6.
• 14.   • Mueller BU, Tannenbaum S, Pizzo PA. Bone marrow aspirates in children with human immunodeficiency virus infection. J Pediatr Hematol Oncol. 1996;18(3):266-71.
• 15.   • Krishnan CR, Sajeeth CI. A comparative study of antiretroviral therapy induced CD T-cell changes among HIV infected patients. Int Res J Pharm. 2014;5(9):726-9.
• 16.   • Hemasri M, Sudhapoornima P, Sowmya Sri CH, Ramya S, Avinash I, Kiran Kumar B. Safety and effectiveness of anti-retroviral drug regimens ZLN and TLE in tertiary care teaching hospital: a prospective observational study. IOSR J Pharm Biol Sci. 2016;11(2):88-96. (Note: I added the year 2016, which corresponds to Volume 11, and corrected the journal abbreviation).
• 17.   • Choi SY, Kim I, Kim NJ, Lee S, Choi Y, Bae J, et al. Haematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean J Hematol. 2011;46(4):253-7.

Data Sharing Statement

Funding